Cargando…

Design of Gold Nanoparticle Vertical Flow Assays for Point-of-Care Testing

Vertical flow assays (VFAs) or flow-through assays have emerged as an alternate type of paper-based assay due to their faster detection time, larger sample volume capacity, and significantly higher multiplexing capabilities. They have been successfully employed to detect several different targets (p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Rongwei, Wang, David, Arain, Hufsa, Mohan, Chandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140445/
https://www.ncbi.nlm.nih.gov/pubmed/35626263
http://dx.doi.org/10.3390/diagnostics12051107
_version_ 1784715098484375552
author Lei, Rongwei
Wang, David
Arain, Hufsa
Mohan, Chandra
author_facet Lei, Rongwei
Wang, David
Arain, Hufsa
Mohan, Chandra
author_sort Lei, Rongwei
collection PubMed
description Vertical flow assays (VFAs) or flow-through assays have emerged as an alternate type of paper-based assay due to their faster detection time, larger sample volume capacity, and significantly higher multiplexing capabilities. They have been successfully employed to detect several different targets (polysaccharides, protein, and nucleic acids), although in a limited number of samples (serum, whole blood, plasma) compared to the more commonly known lateral flow assays (LFAs). The operation of a VFA relies mainly on gravity, coupled with capillary action or external force to help the sample flow through layers of stacked pads. With recent developments in this field, multiple layers of pads and signal readers have been optimized for more user-friendly operation, and VFAs have achieved a lower limit of detection for various analytes than the gold-standard methods. Thus, compared to the more widely used LFA, the VFA demonstrates certain advantages and is becoming an increasingly popular platform for obtaining qualitative and quantitative results in low-resource settings. Considering the wide application of gold nanoparticles (GNPs) in VFAs, we will mostly discuss (1) the design of GNP-based VFA along with its associated advantages/disadvantages, (2) fabrication and optimization of GNP-based VFAs for applications, and (3) the future outlook of flow-based assays for point-of-care testing (POCT) diagnostics.
format Online
Article
Text
id pubmed-9140445
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91404452022-05-28 Design of Gold Nanoparticle Vertical Flow Assays for Point-of-Care Testing Lei, Rongwei Wang, David Arain, Hufsa Mohan, Chandra Diagnostics (Basel) Review Vertical flow assays (VFAs) or flow-through assays have emerged as an alternate type of paper-based assay due to their faster detection time, larger sample volume capacity, and significantly higher multiplexing capabilities. They have been successfully employed to detect several different targets (polysaccharides, protein, and nucleic acids), although in a limited number of samples (serum, whole blood, plasma) compared to the more commonly known lateral flow assays (LFAs). The operation of a VFA relies mainly on gravity, coupled with capillary action or external force to help the sample flow through layers of stacked pads. With recent developments in this field, multiple layers of pads and signal readers have been optimized for more user-friendly operation, and VFAs have achieved a lower limit of detection for various analytes than the gold-standard methods. Thus, compared to the more widely used LFA, the VFA demonstrates certain advantages and is becoming an increasingly popular platform for obtaining qualitative and quantitative results in low-resource settings. Considering the wide application of gold nanoparticles (GNPs) in VFAs, we will mostly discuss (1) the design of GNP-based VFA along with its associated advantages/disadvantages, (2) fabrication and optimization of GNP-based VFAs for applications, and (3) the future outlook of flow-based assays for point-of-care testing (POCT) diagnostics. MDPI 2022-04-28 /pmc/articles/PMC9140445/ /pubmed/35626263 http://dx.doi.org/10.3390/diagnostics12051107 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lei, Rongwei
Wang, David
Arain, Hufsa
Mohan, Chandra
Design of Gold Nanoparticle Vertical Flow Assays for Point-of-Care Testing
title Design of Gold Nanoparticle Vertical Flow Assays for Point-of-Care Testing
title_full Design of Gold Nanoparticle Vertical Flow Assays for Point-of-Care Testing
title_fullStr Design of Gold Nanoparticle Vertical Flow Assays for Point-of-Care Testing
title_full_unstemmed Design of Gold Nanoparticle Vertical Flow Assays for Point-of-Care Testing
title_short Design of Gold Nanoparticle Vertical Flow Assays for Point-of-Care Testing
title_sort design of gold nanoparticle vertical flow assays for point-of-care testing
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140445/
https://www.ncbi.nlm.nih.gov/pubmed/35626263
http://dx.doi.org/10.3390/diagnostics12051107
work_keys_str_mv AT leirongwei designofgoldnanoparticleverticalflowassaysforpointofcaretesting
AT wangdavid designofgoldnanoparticleverticalflowassaysforpointofcaretesting
AT arainhufsa designofgoldnanoparticleverticalflowassaysforpointofcaretesting
AT mohanchandra designofgoldnanoparticleverticalflowassaysforpointofcaretesting